201 related articles for article (PubMed ID: 35059999)
21. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
Law V; Chen Z; Vena F; Smalley I; Macaulay R; Evernden BR; Tran N; Pina Y; Puskas J; Caceres G; Bayle S; Johnson J; Liu JKC; Etame A; Vogelbaum M; Rodriguez P; Duckett D; Czerniecki B; Chen A; Smalley KSM; Forsyth PA
Neuro Oncol; 2022 Oct; 24(10):1673-1686. PubMed ID: 35213727
[TBL] [Abstract][Full Text] [Related]
22. Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.
O'Connor CA; Park JS; Kaley T; Kezlarian B; Edelweiss M; Yang TJ; Park W; Reidy D; Varghese AM; Yu KH; O'Reilly EM
Pancreatology; 2021 Apr; 21(3):599-605. PubMed ID: 33582005
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
Maillie L; Salgado LR; Lazarev S
Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
[TBL] [Abstract][Full Text] [Related]
24. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid.
White MD; Klein RH; Shaw B; Kim A; Subramanian M; Mora JL; Giobbie-Hurder A; Nagabhushan D; Jain A; Singh M; Kuter BM; Nayyar N; Bertalan MS; Stocking JH; Markson SC; Lastrapes M; Alvarez-Breckenridge C; Cahill DP; Gydush G; Rhoades J; Rotem D; Adalsteinsson VA; Mahar M; Kaplan A; Oh K; Sullivan RJ; Gerstner E; Carter SL; Brastianos PK
JAMA Netw Open; 2021 Aug; 4(8):e2120040. PubMed ID: 34369989
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
[TBL] [Abstract][Full Text] [Related]
26. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
27. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD).
Ferguson SD; Fomchenko EI; Guerrieri RA; Glitza Oliva IC
Front Oncol; 2021; 11():800053. PubMed ID: 35096602
[TBL] [Abstract][Full Text] [Related]
28. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.
Pang J; Banerjee A; Tihan T
J Neurooncol; 2008 Mar; 87(1):97-102. PubMed ID: 17987260
[TBL] [Abstract][Full Text] [Related]
29. Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Mills MN; King W; Soyano A; Pina Y; Czerniecki BJ; Forsyth PA; Soliman H; Han HS; Ahmed KA
J Neurooncol; 2022 Apr; 157(2):249-269. PubMed ID: 35244835
[TBL] [Abstract][Full Text] [Related]
30. Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
Glitza IC; Rohlfs M; Guha-Thakurta N; Bassett RL; Bernatchez C; Diab A; Woodman SE; Yee C; Amaria RN; Patel SP; Tawbi H; Wong M; Hwu WJ; Hwu P; Heimberger A; McCutcheon IE; Papadopoulos N; Davies MA
ESMO Open; 2018; 3(1):e000283. PubMed ID: 29387478
[TBL] [Abstract][Full Text] [Related]
31. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
32. Leptomeningeal dissemination in pediatric brain tumors.
Cocito C; Martin B; Giantini-Larsen AM; Valcarce-Aspegren M; Souweidane MM; Szalontay L; Dahmane N; Greenfield JP
Neoplasia; 2023 May; 39():100898. PubMed ID: 37011459
[TBL] [Abstract][Full Text] [Related]
33. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
34. Association between
Papasozomenos H; Guha-Thakurta N; Mayer RR; Weinberg JS; Groves MD; Debnam JM
J Solid Tumors; 2016 Apr; 6(1):1-8. PubMed ID: 30637037
[TBL] [Abstract][Full Text] [Related]
35. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37157199
[TBL] [Abstract][Full Text] [Related]
36. Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
Sener U; Webb M; Breen WG; Neth BJ; Laack NN; Routman D; Brown PD; Mahajan A; Frechette K; Dudek AZ; Markovic SN; Block MS; McWilliams RR; Dimou A; Kottschade LA; Montane HN; Kizilbash SH; Campian JL
J Immunother Precis Oncol; 2024 Feb; 7(1):1-6. PubMed ID: 38327758
[TBL] [Abstract][Full Text] [Related]
37. A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease.
Law V; Baldwin M; Ramamoorthi G; Kodumudi K; Tran N; Smalley I; Duckett D; Kalinski P; Czerniecki B; Smalley KSM; Forsyth PA
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33586709
[TBL] [Abstract][Full Text] [Related]
38. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.
Smalley I; Boire A; Brastianos P; Kluger HM; Hernando-Monge E; Forsyth PA; Ahmed KA; Smalley KSM; Ferguson S; Davies MA; Glitza Oliva IC
Pigment Cell Melanoma Res; 2024 Jan; 37(1):51-67. PubMed ID: 37622466
[TBL] [Abstract][Full Text] [Related]
39. Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
Lowe SR; Wang CP; Brisco A; Whiting J; Arrington J; Ahmed K; Yu M; Robinson T; Oliver D; Etame A; Tran N; Beer Furlan A; Sahebjam S; Mokhtari S; Piña Y; Macaulay R; Forsyth P; Vogelbaum MA; Liu JKC
Neuro Oncol; 2022 Aug; 24(8):1307-1317. PubMed ID: 35092434
[TBL] [Abstract][Full Text] [Related]
40. Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report.
Lai M; Mu T; Liu M; Hu Q; Li J; Huang T; Li Y; Chen S; Cai L
Oncol Lett; 2024 Jul; 28(1):299. PubMed ID: 38751754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
